Macro & Micro-Test's Products & Solutions

Fluorescence PCR | Isothermal Amplification | Colloidal Gold Chromatography | Fluorescence Immunochromatography

Products

  • Dengue NS1 Antigen, IgM/IgG Antibody Dual

    Dengue NS1 Antigen, IgM/IgG Antibody Dual

    This kit is used for in vitro qualitative detection of dengue NS1 antigen and IgM/IgG antibody in serum, plasma and whole blood by immunochromatography, as an auxiliary diagnosis of dengue virus infection.

  • Luteinizing Hormone (LH)

    Luteinizing Hormone (LH)

    The product is used for in vitro qualitative detection of the level of Luteinizing hormone in human urine.

  • SARS-CoV-2 Nucleic Acid

    SARS-CoV-2 Nucleic Acid

    The kit is intended for In Vitro qualitatively detecting the ORF1ab gene and N gene of SARS-CoV-2 in specimen of pharyngeal swabs from suspected cases, patients with suspected clusters or other persons under investigation of SARS-CoV-2 infections.

  • SARS-CoV-2 influenza A influenza B Nucleic Acid Combined

    SARS-CoV-2 influenza A influenza B Nucleic Acid Combined

    This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B. 

  • Real-time fluorescent RT-PCR kit for detecting SARS-CoV-2

    Real-time fluorescent RT-PCR kit for detecting SARS-CoV-2

    This kit is intended to in vitro qualitatively detect the ORF1ab and N genes of novel coronavirus (SARS-CoV-2) in the nasopharyngeal swab and oropharyngeal swab collected from cases and clustered cases suspected with novel coronavirus-infected pneumonia and others required for the diagnosis or differential diagnosis of novel coronavirus infection.

  • SARS-CoV-2 IgM/IgG Antibody

    SARS-CoV-2 IgM/IgG Antibody

    This kit is intended for in vitro qualitative detection of SARS-CoV-2 IgG antibody in human samples of serum/plasma, venous blood and fingertip blood, including SARS-CoV-2 IgG antibody in naturally infected and vaccine-immunized populations.